Safety Monitoring

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter deals with statistical methods used in safety monitoring. The methods described here are those that are used to capture safety signals of a clinical trial in progress rather than to summarize the entire safety profile of a completed trial or integrate the safety data of a particular trial with those of other trials in the same clinical program. The chapter describes some useful steps for the planning for safety monitoring. The statistical methodology is discussed in two parts: methods used by the sponsor and those employed by the data monitoring committee (DMC). The chapter focuses on what statistical methods and operations are most essential for safety monitoring. It concludes with a discussion on the challenges of emerging issues such as adaptive designs, real-time serious adverse events (SAEs) reporting via the internet, the anticipated merger of healthcare delivery and clinical trials, and the high-tech future of drug safety.

Original languageEnglish (US)
Title of host publicationStatistical Methods for Evaluating Safety in Medical Product Development
PublisherWiley Blackwell
Pages293-318
Number of pages26
ISBN (Electronic)9781118763070
ISBN (Print)9781119979661
DOIs
StatePublished - Feb 23 2015

Fingerprint

Safety
Clinical Trials Data Monitoring Committees
Clinical Trials
Internet
Delivery of Health Care
Pharmaceutical Preparations

Keywords

  • Bayesian methods
  • Data monitoring committee (DMC)
  • Drug safety
  • Likelihood methods
  • Safety monitoring
  • Serious adverse events (SAEs)
  • Sponsor staff

ASJC Scopus subject areas

  • Psychology(all)

Cite this

Herson, J. (2015). Safety Monitoring. In Statistical Methods for Evaluating Safety in Medical Product Development (pp. 293-318). Wiley Blackwell. https://doi.org/10.1002/9781118763070.ch11

Safety Monitoring. / Herson, Jay.

Statistical Methods for Evaluating Safety in Medical Product Development. Wiley Blackwell, 2015. p. 293-318.

Research output: Chapter in Book/Report/Conference proceedingChapter

Herson, J 2015, Safety Monitoring. in Statistical Methods for Evaluating Safety in Medical Product Development. Wiley Blackwell, pp. 293-318. https://doi.org/10.1002/9781118763070.ch11
Herson J. Safety Monitoring. In Statistical Methods for Evaluating Safety in Medical Product Development. Wiley Blackwell. 2015. p. 293-318 https://doi.org/10.1002/9781118763070.ch11
Herson, Jay. / Safety Monitoring. Statistical Methods for Evaluating Safety in Medical Product Development. Wiley Blackwell, 2015. pp. 293-318
@inbook{e1e96a4c19d4433491ab469035d70cf1,
title = "Safety Monitoring",
abstract = "This chapter deals with statistical methods used in safety monitoring. The methods described here are those that are used to capture safety signals of a clinical trial in progress rather than to summarize the entire safety profile of a completed trial or integrate the safety data of a particular trial with those of other trials in the same clinical program. The chapter describes some useful steps for the planning for safety monitoring. The statistical methodology is discussed in two parts: methods used by the sponsor and those employed by the data monitoring committee (DMC). The chapter focuses on what statistical methods and operations are most essential for safety monitoring. It concludes with a discussion on the challenges of emerging issues such as adaptive designs, real-time serious adverse events (SAEs) reporting via the internet, the anticipated merger of healthcare delivery and clinical trials, and the high-tech future of drug safety.",
keywords = "Bayesian methods, Data monitoring committee (DMC), Drug safety, Likelihood methods, Safety monitoring, Serious adverse events (SAEs), Sponsor staff",
author = "Jay Herson",
year = "2015",
month = "2",
day = "23",
doi = "10.1002/9781118763070.ch11",
language = "English (US)",
isbn = "9781119979661",
pages = "293--318",
booktitle = "Statistical Methods for Evaluating Safety in Medical Product Development",
publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - Safety Monitoring

AU - Herson, Jay

PY - 2015/2/23

Y1 - 2015/2/23

N2 - This chapter deals with statistical methods used in safety monitoring. The methods described here are those that are used to capture safety signals of a clinical trial in progress rather than to summarize the entire safety profile of a completed trial or integrate the safety data of a particular trial with those of other trials in the same clinical program. The chapter describes some useful steps for the planning for safety monitoring. The statistical methodology is discussed in two parts: methods used by the sponsor and those employed by the data monitoring committee (DMC). The chapter focuses on what statistical methods and operations are most essential for safety monitoring. It concludes with a discussion on the challenges of emerging issues such as adaptive designs, real-time serious adverse events (SAEs) reporting via the internet, the anticipated merger of healthcare delivery and clinical trials, and the high-tech future of drug safety.

AB - This chapter deals with statistical methods used in safety monitoring. The methods described here are those that are used to capture safety signals of a clinical trial in progress rather than to summarize the entire safety profile of a completed trial or integrate the safety data of a particular trial with those of other trials in the same clinical program. The chapter describes some useful steps for the planning for safety monitoring. The statistical methodology is discussed in two parts: methods used by the sponsor and those employed by the data monitoring committee (DMC). The chapter focuses on what statistical methods and operations are most essential for safety monitoring. It concludes with a discussion on the challenges of emerging issues such as adaptive designs, real-time serious adverse events (SAEs) reporting via the internet, the anticipated merger of healthcare delivery and clinical trials, and the high-tech future of drug safety.

KW - Bayesian methods

KW - Data monitoring committee (DMC)

KW - Drug safety

KW - Likelihood methods

KW - Safety monitoring

KW - Serious adverse events (SAEs)

KW - Sponsor staff

UR - http://www.scopus.com/inward/record.url?scp=84947793315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947793315&partnerID=8YFLogxK

U2 - 10.1002/9781118763070.ch11

DO - 10.1002/9781118763070.ch11

M3 - Chapter

AN - SCOPUS:84947793315

SN - 9781119979661

SP - 293

EP - 318

BT - Statistical Methods for Evaluating Safety in Medical Product Development

PB - Wiley Blackwell

ER -